Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.

Source:http://linkedlifedata.com/resource/pubmed/id/15824739

Oncogene 2005 Jun 9 24 25 4138-48

Download in:

View as

General Info

PMID
15824739